EUVIMEDEUVIMED entdecken
Crossref

Advances in Cellular Immunotherapy in Hematologic Malignancies

Mahmoud R. Gaballa, Partow Kebriaei

Advances in Oncology · 2021

DOI: 10.1016/j.yao.2021.02.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Oncology, 2021. Verfasst von Mahmoud R. Gaballa und 1 weiteren Autor:innen. Die Arbeit nennt 65 Literaturangaben. Gefördert von: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Gaballa, M. R., & Kebriaei, P. (2021). Advances in Cellular Immunotherapy in Hematologic Malignancies. Advances in Oncology. https://doi.org/10.1016/j.yao.2021.02.021

Vancouver

Gaballa MR, Kebriaei P. Advances in Cellular Immunotherapy in Hematologic Malignancies. Advances in Oncology. 2021. doi:10.1016/j.yao.2021.02.021

BibTeX
@article{Gaballa2021,
  author = {Gaballa, Mahmoud R. and Kebriaei, Partow},
  title = {Advances in Cellular Immunotherapy in Hematologic Malignancies},
  journal = {Advances in Oncology},
  year = {2021},
  doi = {10.1016/j.yao.2021.02.021}
}
Kostenlos starten →